Sensory neural hearing loss in Behcet's disease successfully controlled with infliximab, case report and review of literature.

Autor: Faisal M; Hamad Medical Corporation Doha Qatar., Barjas H; Hamad Medical Corporation Doha Qatar., Alwassiti W; Hamad Medical Corporation Doha Qatar., Omer W; Hamad Medical Corporation Doha Qatar., Abdulla N; Hamad Medical Corporation Doha Qatar.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2022 Oct 12; Vol. 10 (10), pp. e6457. Date of Electronic Publication: 2022 Oct 12 (Print Publication: 2022).
DOI: 10.1002/ccr3.6457
Abstrakt: Behcet's disease is a systemic autoimmune disorder occasionally associated with otological manifestations, including sensorineural hearing loss. We are reporting a case of Behcet's disease, which was complicated by sensorineural hearing loss and managed successfully with anti-TNF agent Infliximab.
Competing Interests: The authors have no conflict of interest to declare.
(© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje